Shock Cardiogenic clinical trials

Explore recruiting shock cardiogenic clinical trials.

Recruiting shock cardiogenic studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Shock Cardiogenic trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy and Safety of cangrelor on top of anticoagUlation in patients with myocaRdial infarction related cardiogenic shock/cardiac arrest receiVIng VA-ECMO and/or Impella support – a phase 2, single arm, single center trial

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Shock Cardiogenic trials by city

Shock Cardiogenic in Toronto Shock Cardiogenic in Vancouver Shock Cardiogenic in Montreal Shock Cardiogenic in Calgary Shock Cardiogenic in Edmonton Shock Cardiogenic in Ottawa Shock Cardiogenic in Winnipeg Shock Cardiogenic in Quebec City Shock Cardiogenic in Hamilton Shock Cardiogenic in Kitchener Shock Cardiogenic in London Shock Cardiogenic in Halifax Shock Cardiogenic in New York Shock Cardiogenic in Los Angeles Shock Cardiogenic in Chicago Shock Cardiogenic in Houston

Shock Cardiogenic clinical trials

Recruiting shock cardiogenic studies right now

Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock

Physiology of Unloading VA ECMO Trial

The Role of Swan-Ganz Catheter in Hemodynamic Resuscitation for Patients With Cardiogenic Shock

Efferon CT Hemoadsorption for Cardiogenic Shock in Acute Myocardial Infarction

Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO

CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock

Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction

Pulmonary Artery Catheter in Cardiogenic Shock Trial

Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock

Early Beta Blocker Administration in STEMI Patients With SCAI B Status

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

Ivabradine in the Acute Management of Cardiogenic Shock

Also recruiting in Europe

Efficacy and Safety of cangrelor on top of anticoagUlation in patients with myocaRdial infarction related cardiogenic shock/cardiac arrest receiVIng VA-ECMO and/or Impella support – a phase 2, single arm, single center trial

Shock Cardiogenic trials by city

Other conditions